LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
| Research and development (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $14.6B | +23.4% | 17.4% | 10.8% |
| Research and development (TTM) | $14.6B |
|---|---|
| YoY | +23.4% |
| 5-year CAGR | 17.4% |
| 10-year CAGR | 10.8% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $13.3B | +21.3% |
| 2024 | $11.0B | +18.0% |
| 2023 | $9.3B | +29.5% |
| 2022 | $7.2B | +3.8% |
| 2021 | $6.9B | +16.0% |
| 2020 | $6.0B | +6.8% |
| 2019 | $5.6B | +10.8% |
| 2018 | $5.1B | −0.9% |
| 2017 | $5.1B | −4.0% |
| 2016 | $5.3B | +10.7% |
| 2015 | $4.8B | +1.3% |
| 2014 | $4.7B | −14.4% |
| 2013 | $5.5B | +4.8% |
| 2012 | $5.3B | +5.1% |
| 2011 | $5.0B | +2.8% |
| 2010 | $4.9B | +12.9% |
| 2009 | $4.3B | +12.6% |
| 2008 | $3.8B | +10.2% |
| 2007 | $3.5B | — |